
INR 100 UCLA Medical Plaza, Suites 205-210
Los Angeles, California 90095 (310) 824-6199 Edward Tobinick MD,
Medical Director
New Orange County office:
361 Hospital Road, Suite 428 Newport Beach, California 92663

Rapid
improvement in Alzheimer's, beginning within minutes*
Video1
Video2
(Australia)
Video3
Video4
Video5
Video6
Video7
Video8
Video9
Video10
Video11
Video12
Video13
(Mexico)
Video14
Video15
(Espanol)
Video16
Families are flying to the INR®
in Los Angeles from around the world to begin the INR's unique
treatment for Alzheimer's and PPA (see videos above)
*see: Edward Tobinick
MD, Perispinal etanercept for neuroinflammatory
disorders Drug Discovery Today 2009 Feb;14(3-4):168-77.
(download abstracts PDF)
Perispinal etanercept for Alzheimer's
is a patented[1], off-label treatment method invented at the INR.
It is available in the U.S. exclusively through INR
trained and licensed physicians. Patients and physicians are coming
to the INR from around the world for treatment and
physician training.
as seen in Nature Clinical Practice
Neurology, in
a university
press release, on Medscape,
the BBC, New Scientist, CNN, Fox News, ABC News, Bloomberg
News, Reuters Health, the Times Online (U.K.), the Daily Telegraph(U.K.),
and UPI.
Appointments
and information (310) 824-6199
In the News: Epidural
etanercept for lumbosacral radiculopathy, an off-label
treatment method invented at the INR, has positive
results in randomized, double-blind, placebo-controlled clinical
trial conducted at Walter Reed Army Medical Center (link)
Review article published:
Edward Tobinick MD.Tumour necrosis factor modulation for treatment
of Alzheimer's disease: rationale and current evidence. CNS
Drugs. September 2009: 23(9):713-25
Recent and upcoming conference presentations by
Edward Tobinick MD, Director of the INR:
TNF antagonists for
neurological disorders: from concept to the clinic, scheduled presentation at GTC Bio's 5th
Modern Drug Discovery & Development Conference, October 14-1,
2009, San Diego, California
TNF
Modulation for treatment of Alzheimer's Disease, at the Targeting Alzheimer's with
Novel Therapeutics Conference at the World Pharmaceutical
Congress, Philadelphia, June 11, 2009 (more
information)
Perispinal etanercept
for Alzheimer's disease,
at the 3rd International Scientific Conference Restauracion Neurologica
2009, Havana, Cuba March 11, 2009

<Map
and Directions><Appointments><Physician Training Program><Terms of Use><Memory
Disorders Program-detailed brochure (PDF)><Videos>
Copyright ©2009,
the Institute for Neurological Research® (INR®), a private
medical group, inc., all rights reserved. [1]U.S. patents 6,537,549;
6,982,089; 7,214,658; and Australian patent 758,523; and additional
issued and pending U.S. and foreign patents. These patents are
assigned to TACT IP LLC. Please
see the medical and legal disclaimer.